Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Ashley Cimino-Mathews
affiliation not provided to SSRN
Contact
affiliation not provided to SSRN
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
42
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
A Composite 18f-Fdg Pet/Ct and Her2 Tissue-Based Biomarker to Predict Response to Neoadjuvant Pertuzumab and Trastuzumab in Her2-Positive Breast Cancer (Tbcrc026)
Number of pages: 33
Posted: 27 Nov 2024
Maeve Hennessy
, Ashley Cimino-Mathews,
Jodi M. Carter
,
Jennifer M. Kachergus
,
Yaohua Ma
,
Jeffrey P. Leal
,
Lilja B. Solnes
,
Vandana G. Abramson
,
Lisa A. Carey
,
Mothaffar F. Rimawi
,
Jennifer Specht
,
Ana Maria Storniolo
,
Christos Vaklavas
,
Ian Krop
,
Eric Winer
,
Rita Denbow
,
Vicente Valero
,
Antonio Wolff
,
Richard L. Wahl
,
Chiung-Yu Huang
,
Vered Stearns
,
E. Aubrey Thompson
and
Roisin M. Connolly
Cork University Hospital,
affiliation not provided to SSRN
, University of Alberta, Mayo Clinic, Mayo Clinic, Johns Hopkins University,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
, Baylor College of Medicine, University of Washington, Indiana University - School of Medicine,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
, University of Texas at Houston - MD Anderson Cancer Center, Johns Hopkins University,
affiliation not provided to SSRN
,
affiliation not provided to SSRN
, Cornell University - Weill Cornell Medicine, Mayo Clinic and
affiliation not provided to SSRN
Downloads
42
(1,170,409)
View PDF
Download
Abstract:
18F-FDG PET/CT, HER2-Biomarkers, breast cancer, Neoadjuvant
Feedback